Page last updated: 2024-09-03

caprylates and Chemical and Drug Induced Liver Injury, Chronic

caprylates has been researched along with Chemical and Drug Induced Liver Injury, Chronic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Jiao, A; Liang, Y; Qin, J; Song, J; Yang, B1
Chen, W; Liang, X; Pan, R; Wang, G; Wu, X; Wu, Y; Zhang, H; Zhao, J1

Other Studies

2 other study(ies) available for caprylates and Chemical and Drug Induced Liver Injury, Chronic

ArticleYear
In Silico Analysis Identifies the Anti-Liver Injury Targets of Diammonium Glycyrrhizinate: Validated in Perfluorooctanoic Acid-Lesioned Mouse Model.
    Chemistry & biodiversity, 2022, Volume: 19, Issue:8

    Topics: Animals; Caprylates; Caspase 3; Chemical and Drug Induced Liver Injury, Chronic; Cyclooxygenase 2; Disease Models, Animal; Fluorocarbons; Glycyrrhizic Acid; Mice; Molecular Docking Simulation

2022
Perfluorooctanoic acid-induced liver injury is potentially associated with gut microbiota dysbiosis.
    Chemosphere, 2021, Volume: 266

    Topics: Animals; Caprylates; Chemical and Drug Induced Liver Injury, Chronic; Dysbiosis; Fluorocarbons; Gastrointestinal Microbiome; Mice; Mice, Inbred C57BL; Phylogeny; RNA, Ribosomal, 16S

2021